Articles
25-Apr-2019
Beth Gaudin, Senior Consultant and Pharma Lead at Forster Communications, explores how pharma can create an engaged workforce.
An engaged and motivated workforce is near the top of the wish list for almost any employer. It improves turnover, sickness and presenteeism rates, and research has shown that companies with an engaged workforce outperform those without by a whopping 202%[1]. For many businesses, this ambition does not always meet up with the reality. Worldwide just 15% of employees are engaged with the work they do[2]. It’s a constant source of concern not just for HR teams, but for entire companies. No wonder then, that a recent survey found that for 40% of HR professionals thought employee engagement would be one of their biggest challenges for 2019[3]. Recruitment…
An engaged and motivated workforce is near the top of the wish list for almost any employer. It improves turnover, sickness and presenteeism rates, and research has shown that companies with an engaged workforce outperform those without by a whopping 202%[1]. For many businesses, this ambition does not always meet up with the reality. Worldwide just 15% of employees are engaged with the work they do[2]. It’s a constant source of concern not just for HR teams, but for entire companies. No wonder then, that a recent survey found that for 40% of HR professionals thought employee engagement would be one of their biggest challenges for 2019[3]. Recruitment…
Global Serialization: Russian Track and Trace Readiness
Excellis Health is the leading provider of strategy and implementation consulting services within the Life Sciences and Healthcare industries. Here, Christoph Krähenbühl, Senior Director of Excellis Europe, explains the challenge the new Russian traceability regulations present to the pharma industry, and how all participants in the supply chain must properly prepare to ensure that they become compliant within this new environment. On 1 January 2020, Russia will introduce a new, compulsory system for tracking pharmaceuticals from manufacturer to end user. This new legislation should be considered alongside wider global efforts to enhance quality control and put in place protection against fake and counterfeit medicines. Recent r…
Excellis Health is the leading provider of strategy and implementation consulting services within the Life Sciences and Healthcare industries. Here, Christoph Krähenbühl, Senior Director of Excellis Europe, explains the challenge the new Russian traceability regulations present to the pharma industry, and how all participants in the supply chain must properly prepare to ensure that they become compliant within this new environment. On 1 January 2020, Russia will introduce a new, compulsory system for tracking pharmaceuticals from manufacturer to end user. This new legislation should be considered alongside wider global efforts to enhance quality control and put in place protection against fake and counterfeit medicines. Recent r…
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it?
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it? The more we talk about death, the easier it will be to normalise the subject and feel less fearful of the unknown. Whether you want to talk about it or not, one aspect of death that you can’t hide from is deciding what you want to happen to your body when you pass. It’s not a particularly pleasant thought but it is one you’ll eventu…
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it? The more we talk about death, the easier it will be to normalise the subject and feel less fearful of the unknown. Whether you want to talk about it or not, one aspect of death that you can’t hide from is deciding what you want to happen to your body when you pass. It’s not a particularly pleasant thought but it is one you’ll eventu…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes.
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Acto…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Acto…
Regulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future employers and get essential advice from some of the most respected and influential leaders in the field of regulatory affairs
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency.
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency. One of the main potential beneficiaries of improved information management in life sciences is Regulatory Affairs – a department which must prepare and manage data ad infinitum, to keep products on the market. Here, ProductLife Group’s Erick Gaussens sets out three persuasive reasons why RA teams should champion the digital tra…
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency. One of the main potential beneficiaries of improved information management in life sciences is Regulatory Affairs – a department which must prepare and manage data ad infinitum, to keep products on the market. Here, ProductLife Group’s Erick Gaussens sets out three persuasive reasons why RA teams should champion the digital tra…
Artificial intelligence (AI) is creation of unique systems using algorithms and software that can perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence is used in healthcare for approximation of human cognition and analysis of complex medical and diagnostic imaging data.
Artificial intelligence (AI) is creation of unique systems using algorithms and software that can perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence…
Artificial intelligence (AI) is creation of unique systems using algorithms and software that can perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence…
Cytomegalovirus treatment market, primarily based on off-label drugs prescription, is expected to grow rapidly in the coming years. Untapped opportunities for new companies to develop a technology solely for cytomegalovirus treatment spotted
A new study by the company, titled ' Cytomegalovirus Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028,' points out the key structural outlook for the cytomegalovirus treatment market. A large number of people are infected by Cytomegalovirus (CMV) virus during their life course, mostly in indications that are invasively treated like organ transplantation and stem cell transplantation. The virus is found active post treatment or later stages of any other treatment like mentioned before. Cytomegaloviruses are among…
A new study by the company, titled ' Cytomegalovirus Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028,' points out the key structural outlook for the cytomegalovirus treatment market. A large number of people are infected by Cytomegalovirus (CMV) virus during their life course, mostly in indications that are invasively treated like organ transplantation and stem cell transplantation. The virus is found active post treatment or later stages of any other treatment like mentioned before. Cytomegaloviruses are among…
12-Apr-2019
PharmiWeb.jobs a new jobs board
PharmiWeb are very excited to be launch the new version of our world class Job Board PharmiWeb.jobs, as well as the latest Pharma News Portal PharmiWeb.com.To search for the best selections of Pharma Jobs in Europe visit pharmiweb.jobsTo find the widest range of pharma news, events and articles, search on this site! PharmiWeb are partnering with numerous providers and organisations such as: Jooble To find our Jobs and other similar jobs please check Jooble. Jooble is a job search engine operated in 70 countries worldwide.
PharmiWeb are very excited to be launch the new version of our world class Job Board PharmiWeb.jobs, as well as the latest Pharma News Portal PharmiWeb.com.To search for the best selections of Pharma Jobs in Europe visit pharmiweb.jobsTo find the widest range of pharma news, events and articles, search on this site! PharmiWeb are partnering with numerous providers and organisations such as: Jooble To find our Jobs and other similar jobs please check Jooble. Jooble is a job search engine operated in 70 countries worldwide.
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs, whilst extending the scope of its research and improving patient and clinical experiences.
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs,…
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs,…
In its first ever pan European research on the life sciences industry, Kelly asked almost 1,400 of its workers their opinions on everything from work life design, to AI, through to what matters most to them. With respondents from Germany, France, the UK, Ireland, the Netherlands, Switzerland and Italy it was surprising to find so many commonalities between each of the countries.
The life sciences are all about diversity and movement, which is why Pharma and Medical Devices companies may need more than just a good reputation after Brexit. As the United Kingdom drifts towards an exit from the European Union, the Pharma and Medical Devices sectors are preparing for all eventualities. However, the employment landscape is already highly competitive and it is shifting. With a widespread skills s…
The life sciences are all about diversity and movement, which is why Pharma and Medical Devices companies may need more than just a good reputation after Brexit. As the United Kingdom drifts towards an exit from the European Union, the Pharma and Medical Devices sectors are preparing for all eventualities. However, the employment landscape is already highly competitive and it is shifting. With a widespread skills s…
13-Feb-2019
Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd, looks at bioconcentration and biomagnification and what is being done to protect our planet.
The environment and the organisms living in it are continuously exposed to a wide range of chemicals. From chlorine-based solutions that remove bacteria from water to pesticides that treat and protect crops. However, through bioconcentration and the theory of biomagnification, some of these chemicals can become dangerous to our world. Here, Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd, looks at bioconcentration and biomagnification and what is being done to protect our planet. With every chemical pro…
The environment and the organisms living in it are continuously exposed to a wide range of chemicals. From chlorine-based solutions that remove bacteria from water to pesticides that treat and protect crops. However, through bioconcentration and the theory of biomagnification, some of these chemicals can become dangerous to our world. Here, Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd, looks at bioconcentration and biomagnification and what is being done to protect our planet. With every chemical pro…
13-Feb-2019
Rachael Benstead, senior aquatic ecotoxicologist at Translational science and research organisation, Fera Science Ltd, helps plot a roadmap to a future in which we can take advantage of the benefits of nanotechnology in water and mitigate against the drawbacks.
It is entirely conceivable that the engineered nanoparticles that seem like today's water treatment panacea, could be tomorrow's ecological dynamite. The potential for the use of nanoparticles in water treatment such as water filtration is too compelling to ignore, despite the potential risks. Here, Rachael Benstead, senior aquatic ecotoxicologist at Translational science and research organisation, Fera Science Ltd, helps plot a roadmap to a future in which we can take advantage of the benefits of nanotechnology in water and mitiga…
It is entirely conceivable that the engineered nanoparticles that seem like today's water treatment panacea, could be tomorrow's ecological dynamite. The potential for the use of nanoparticles in water treatment such as water filtration is too compelling to ignore, despite the potential risks. Here, Rachael Benstead, senior aquatic ecotoxicologist at Translational science and research organisation, Fera Science Ltd, helps plot a roadmap to a future in which we can take advantage of the benefits of nanotechnology in water and mitiga…
28-Jan-2019
Paul Mannion, project engineer at engineering solutions provider Boulting, explains the considerations that should be made when designing for builds in hazardous environments.
When Mount Vesuvius erupted in AD79, the citizens of Pompeii were not prepared for the devastation that followed. Having lain dormant for the last 71 years, the Italian authorities continue to prepare for the next eruption from one of the most dangerous active volcanos in the world. Here, Paul Mannion, project engineer at engineering solutions provider Boulting, explains the considerations that should be made when designing for builds in hazardous environments. The Dangerous Substances and Explosive Atmosphere Regulations 2002 (DSEAR), defines a hazardous area as “any place in which an explosive atmo…
When Mount Vesuvius erupted in AD79, the citizens of Pompeii were not prepared for the devastation that followed. Having lain dormant for the last 71 years, the Italian authorities continue to prepare for the next eruption from one of the most dangerous active volcanos in the world. Here, Paul Mannion, project engineer at engineering solutions provider Boulting, explains the considerations that should be made when designing for builds in hazardous environments. The Dangerous Substances and Explosive Atmosphere Regulations 2002 (DSEAR), defines a hazardous area as “any place in which an explosive atmo…
28-Jan-2019
Almost half of over 65s in England take at least five different drugs each day, according to a 2017 study conducted at the University of Cambridge. Here, Oliver Pittock, from medical packaging experts, Valley Northern, explores what can be done to help the ageing population keep safe around prescribed medications and avoid mishaps.
Almost half of over 65s in England take at least five different drugs each day, according to a 2017 study conducted at the University of Cambridge. The increasing rates of polypharmacy, taking multiple medications simultaneously, means that prescribing for the elderly is becoming an increasingly important aspect of clinical patient care. Here, Oliver Pittock, managing director at medical packaging experts, Valley Northern, explores what can be done to help th…
Almost half of over 65s in England take at least five different drugs each day, according to a 2017 study conducted at the University of Cambridge. The increasing rates of polypharmacy, taking multiple medications simultaneously, means that prescribing for the elderly is becoming an increasingly important aspect of clinical patient care. Here, Oliver Pittock, managing director at medical packaging experts, Valley Northern, explores what can be done to help th…
14-Jan-2019
Learning the microbead lesson
A UK-wide prohibition on the use of plastic microbeads came into effect in 2018, but what fundamental lessons can we learn from this high profile case? Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd. explains all. Figures from The Department for the Environment, Food and Rural Affairs (DEFRA) suggest that an estimated 680 tonnes of microbeads are used in cosmetic products every year. These tiny pieces of plastic, used for exfoliation in rinse-off products such as toothpastes, face scrubs and shower gels, inevitably end up contaminating the environment. With particle sizes varying from 10 micrometers up to 1 millimetre, microbeads are the same size as much of the…
A UK-wide prohibition on the use of plastic microbeads came into effect in 2018, but what fundamental lessons can we learn from this high profile case? Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd. explains all. Figures from The Department for the Environment, Food and Rural Affairs (DEFRA) suggest that an estimated 680 tonnes of microbeads are used in cosmetic products every year. These tiny pieces of plastic, used for exfoliation in rinse-off products such as toothpastes, face scrubs and shower gels, inevitably end up contaminating the environment. With particle sizes varying from 10 micrometers up to 1 millimetre, microbeads are the same size as much of the…
Preclinical IPOs: Is the window starting to close?
A record-breaking year is on the cards, as biotechnology companies continue the trend of pre-clinical initial public offerings (IPOs). As of July, six young firms had raised almost $800million through their IPOs, despite none having permission from regulators to start clinical trials in humans.[1] These companies are now generating significant returns. For example, the most recent preclinical IPO by Gritstone Oncology Inc was initially valued at $100 million, and as of 12 December 2018 has a market value of $731 million.1 Pre-clinical valuations Traditionally, there are two good times for biotech companies to go public: right after proof or concept in humans or upon the publication of promising, pivotal data. But these pre-cl…
A record-breaking year is on the cards, as biotechnology companies continue the trend of pre-clinical initial public offerings (IPOs). As of July, six young firms had raised almost $800million through their IPOs, despite none having permission from regulators to start clinical trials in humans.[1] These companies are now generating significant returns. For example, the most recent preclinical IPO by Gritstone Oncology Inc was initially valued at $100 million, and as of 12 December 2018 has a market value of $731 million.1 Pre-clinical valuations Traditionally, there are two good times for biotech companies to go public: right after proof or concept in humans or upon the publication of promising, pivotal data. But these pre-cl…
07-Feb-2019
~ Unpacking the potential of smart packaging ~
One of the biggest challenges for manufacturers of consumable goods is how to extend product shelf life while ensuring safety. Over the past hundred years, the food and beverage industry has invested billions of pounds in researching suitable packaging, but what can the pharmaceutical industry learn from this?
Here, Dale Pittock, sales director of pharmacy consumables provider Valley Northern, explores the latest developments in the smart packaging market. Imagine if a packet of antibiotics could tell a patient whether it had been opened and which pill had been taken and at what time. Then, imagine if things could be taken a step further and the medication could alert patients when it was time to take the next one, then feed this informat…
Here, Dale Pittock, sales director of pharmacy consumables provider Valley Northern, explores the latest developments in the smart packaging market. Imagine if a packet of antibiotics could tell a patient whether it had been opened and which pill had been taken and at what time. Then, imagine if things could be taken a step further and the medication could alert patients when it was time to take the next one, then feed this informat…
30-Nov-2018
~ Pharmacy and healthcare supplier releases advisory whitepaper ~
Leading pharmacy and healthcare consumables supplier, Valley Northern, has released its latest whitepaper, exploring the increasing issue of patient non-adherence. The whitepaper, which can be downloaded directly from the Valley Northern website, looks at why non-adherence is an issue and how those across the healthcare industry can help to tackle it. Download the whitepaper here: Valley Northern Downloads.Across the United Kingdom, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of a recent industry report admitted to not taking their medication as prescribed. The issue of patient non-adherence is a big issue, particularly when patients try to take thei…
Leading pharmacy and healthcare consumables supplier, Valley Northern, has released its latest whitepaper, exploring the increasing issue of patient non-adherence. The whitepaper, which can be downloaded directly from the Valley Northern website, looks at why non-adherence is an issue and how those across the healthcare industry can help to tackle it. Download the whitepaper here: Valley Northern Downloads.Across the United Kingdom, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of a recent industry report admitted to not taking their medication as prescribed. The issue of patient non-adherence is a big issue, particularly when patients try to take thei…
3rd World Congress On Applied Microbiology
Microbiology Conference | Microbiology Conferences
Brussels, Belgium
May 15-16, 2019
Applied Microbiology Conference 2019 which is going to be held on May 15-16, 2019, at Brussels, Belgium by Meeting International . 3rd World Congress On Applied Microbiology based on the theme Emerging Trends And Innovations In Microbial Research. 3rd World Congress On Applied Microbiology is delighted to invite all the participants globally to attend the conference which will be held in Brussels, Belgium during May 15-16, 2019. It will bring together world-class highly reputed microbiologist, Professor, Scientist, Researchers, Doctors, Academicians, Business professionals, Government Officials, and young scientist to discuss strategies for Microbial diseas…
Applied Microbiology Conference 2019 which is going to be held on May 15-16, 2019, at Brussels, Belgium by Meeting International . 3rd World Congress On Applied Microbiology based on the theme Emerging Trends And Innovations In Microbial Research. 3rd World Congress On Applied Microbiology is delighted to invite all the participants globally to attend the conference which will be held in Brussels, Belgium during May 15-16, 2019. It will bring together world-class highly reputed microbiologist, Professor, Scientist, Researchers, Doctors, Academicians, Business professionals, Government Officials, and young scientist to discuss strategies for Microbial diseas…
